SYMBICORT 4.5 ug/1 (Budesonide and Formoterol Fumarate Dihydrate AEROSOL) 4.5 ug/1

SYMBICORT 4.5 ug/1 is a combination inhaler containing Budesonide and Formoterol Fumarate Dihydrate. It is used for managing respiratory conditions like asthma and COPD. This aerosol formulation is designed for inhalation and is manufactured by AstraZeneca Pharmaceuticals LP.

Strength

4.5 ug/1

Pack Size

1 POUCH in 1 CARTON (0186-0372-20) / 1 CANISTER in 1 POUCH / 120 AEROSOL in 1 CANISTER

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

SYMBICORT 4.5 ug/1 is commonly used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). The Budesonide component is a corticosteroid that helps reduce inflammation in the lungs, while Formoterol is a long-acting bronchodilator that helps open the airways. This combination is often prescribed to improve breathing and reduce symptoms such as wheezing, shortness of breath, and coughing.

Side Effects

When used as directed, SYMBICORT 4.5 ug/1 may help improve lung function and reduce symptoms associated with respiratory conditions. Some users may experience common effects such as throat irritation, hoarseness, or a mild headache. It is important to follow the prescribed dosage and administration instructions to minimize potential side effects.

Precautions & Warnings

SYMBICORT 4.5 ug/1 should be used with caution in individuals with certain medical conditions, such as heart disease or diabetes. It is important to inform your healthcare provider about any existing health conditions or medications you are taking. Always use the inhaler as directed and store it properly to maintain its effectiveness.

Avoid Interactions

SYMBICORT 4.5 ug/1 may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is advisable to consult with a healthcare provider before combining SYMBICORT with other treatments. Additionally, avoid using alcohol or other respiratory medications without medical advice.

Frequently Asked Questions

SYMBICORT 4.5 ug/1 is used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).

SYMBICORT 4.5 ug/1 is administered via inhalation using the provided inhaler. Follow the instructions provided by your healthcare provider for proper use.

Common effects may include throat irritation, hoarseness, or a mild headache. Always use as directed to minimize potential side effects.

SYMBICORT 4.5 ug/1 may interact with other medications. Consult your healthcare provider before combining it with other treatments.

Store SYMBICORT 4.5 ug/1 at room temperature and keep it away from moisture and heat. Always follow the storage instructions provided.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.